Table 4.
NLR and PLR of annexin A1 serum level in cancerous, benign and normal groups
| NLR and PLR of serum annexin A1 for differentiating lung cancer patients from normal people | ||||
|
| ||||
| Interval | Positive | Negative | Likelihood ratio | 95% CI |
|
| ||||
| 1-2 | 0 | 25 | 0.000 | 0.000 to 0.312 |
| 2-3 | 0 | 60 | 0.000 | 0.000 to 0.128 |
| 3-4 | 0 | 55 | 0.000 | 0.000 to 0.140 |
| 4-5 | 41 | 101 | 0.388 | 0.282 to 0.534 |
| 5-6 | 156 | 15 | 9.934 | 6.017 to 16.402 |
| 6-7 | 71 | 0 | ∞ | 8.446 to ∞ |
| Total | 268 | 256 | ||
|
| ||||
| NLR and PLR of serum annexin A1 for differentiating lung cancer patients from benign lung disease patient | ||||
|
| ||||
|---|---|---|---|---|
| Interval | Positive | Negative | Likelihood ratio | 95% CI |
|
| ||||
| 1.5-2.0 | 0 | 6 | 0.000 | 0.000 to 1.494 |
| 2.0-2.5 | 0 | 17 | 0.000 | 0.000 to 0.400 |
| 2.5-3.0 | 0 | 16 | 0.000 | 0.000 to 0.426 |
| 3.0-3.5 | 0 | 36 | 0.000 | 0.000 to 0.185 |
| 3.5-4.0 | 0 | 27 | 0.000 | 0.000 to 0.248 |
| 4.0-4.5 | 0 | 20 | 0.000 | 0.000 to 0.338 |
| 4.5-5.0 | 41 | 35 | 0.962 | 0.635 to 1.455 |
| 5.0-5.5 | 76 | 53 | 1.177 | 0.870 to 1.592 |
| 5.5-6.0 | 80 | 7 | 9.382 | 4.424 to 19.894 |
| 6.0-6.5 | 71 | 4 | 14.571 | 5.407 to 39.265 |
| Total | 268 | 221 | ||
NLR, negative likelihood ratio; PLR, positive likelihood ratio; 95% CI, 95% confidence interval.